Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer

Francesca Nardi(Brigham and Women's Hospital), Karen Cichowski(Brigham and Women's Hospital)
Journal of Clinical Investigation
June 29, 2023
Cited by 20


Related Papers